Common Names: Kurogane holly
Study identified and analyzed the main active components and mechanism of Ilex rotunda in treating ulcerative colitis, providing potential insights for its use in gastrointestinal diseases.
Researchers investigated the potential of Pedunculoside (PE) in treating non-small cell lung cancer (NSCLC) and its resistance to Gefitinib, a common therapy. PE, derived from Ilex rotunda Thunb., has demonstrated anti-inflammatory, lipid-lowering, and anti-tumor effects. The study aimed to understand the therapeutic effect and underlying mechanisms of PE. This research is significant as it may provide insights into new treatment options for NSCLC and combating Gefitinib resistance.
A study investigated the antioxidant composition of Thunb., a plant commonly used for medicinal purposes. Twig extracts showed the best potential for antioxidant capacity, and the -butanol fraction had the highest antioxidant effect. Eight marker compounds were isolated, and their structures determined. One compound (4,5-dicaffeoylquinic acid) showed significant antioxidant activity and penetrated the blood-brain barrier. This compound could be used as a potential therapeutic candidate for central nervous system drug discovery.